Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
![]()
The minute particles float in the exhaled airstream into the instrument, resulting in a sample that allows for precise biomarker results
Lung cancer has become an epidemic in recent years. According to statistics by Lungevity, one in sixteen people in the US are supposed to be diagnosed with lung cancer in their lifetime. Center for Disease Control and Prevention (CDC) states that smoking is the number one risk factor for lung cancer, causing about 80 to 90 percent of lung cancers in the U.S. Many healthcare companies are looking for solutions to pave the way for early detection and to provide more personalized and effective treatment of lung diseases Read More
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info